Your browser doesn't support javascript.
loading
Severe West Nile virus and Sars-CoV-2 infections in a patient with thymoma and anti-type I IFN antibodies.
Barzaghi, Federica; Visconti, Camilla; Pipitone, Giovanni Battista; Bondesan, Simone; Molli, Giulia; Giannelli, Stefania; Sartirana, Claudia; Lampasona, Vito; Bazzigaluppi, Elena; Brigatti, Cristina; Gervais, Adrian; Bastard, Paul; Din, Chiara Tassan; Molinari, Chiara; Piemonti, Lorenzo; Casanova, Jean-Laurent; Carrera, Paola; Casari, Giorgio; Aiuti, Alessandro.
Afiliação
  • Barzaghi F; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Visconti C; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Pipitone GB; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bondesan S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Molli G; Università Vita-Salute San Raffaele, Milan, Italy.
  • Giannelli S; Laboratory of Clinical Genomics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Sartirana C; Laboratory of Clinical Genomics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lampasona V; Laboratory of Clinical Genomics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bazzigaluppi E; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Brigatti C; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Gervais A; San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bastard P; San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Din CT; San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Molinari C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Piemonti L; Paris Cité University, Imagine Institute, Paris, France.
  • Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Carrera P; Paris Cité University, Imagine Institute, Paris, France.
  • Casari G; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Aiuti A; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, EU.
J Infect Dis ; 2024 Jul 08.
Article em En | MEDLINE | ID: mdl-38976510
ABSTRACT
The current study aimed to investigate determinants of severity in a previously healthy patient who experienced two life-threatening infections, from West Nile Virus and SARS-CoV2. During COVID19 hospitalization he was diagnosed with a thymoma, retrospectively identified as already present at the time of WNV infection. Heterozygosity for p.Pro554Ser in the TLR3 gene, which increases susceptibility to severe COVID-19, and homozygosity for CCR5 c.554_585del, associated to severe WNV infection, were found. Neutralizing anti-IFN-α and anti-IFN-ω auto-antibodies were detected, likely induced by the underlying thymoma and increasing susceptibility to both severe COVID-19 pneumonia and West Nile encephalitis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Dis Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Dis Ano de publicação: 2024 Tipo de documento: Article